4D Lifetec AG is a highly innovative Swiss startup developing the 4D Lifetest™ – an innovative, standardized, cost effective ultra-precise blood test for the early detection of cancer.
Location: Switzerland, Zug, Cham
Employees: 1-10
Total raised: $27.86M
Founded date: 2014
Investors 1
| Date | Name | Website |
| 10.02.2023 | VentureLab | venturelab... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 18.10.2023 | - | $25.92M | - |
| 15.07.2022 | Series B | $1.94M | - |
Mentions in press and media 15
| Date | Title | Description |
| 18.10.2023 | 4D Lifetec secures CHF 23.3 million to enhance cancer diagnosis | |
| 18.10.2023 | Empowering early cancer detection: 4D Lifetec secures CHF 23.3 million in a share and investment deal with Xlife Sciences | Empowering early cancer detection: 4D Lifetec secures CHF 23.3 million in a share and investment deal with Xlife Sciences 18.10.2023 13:08, Rita Longobardi linkedIn facebook twitter instagram youtube --> In a healthcare revolution, Xlife... |
| 21.02.2023 | 4D LifeTec establishes a presence in the US market | |
| 13.01.2023 | Seasoned executives to drive startups in the next phase | |
| 04.01.2023 | Molecular Diagnostics to industrialise 4D Lifetest | |
| 18.07.2022 | 4D Lifetec banks CHF 1.9 in series B round | |
| 15.07.2022 | 4D Lifetec announces successful first closing of CHF 1.9 million Series B financing to launch its early lung cancer detection liquid biopsy assay 4D Lifetest™ Lung Dx in Europe | 4D Lifetec announces successful first closing of CHF 1.9 million Series B financing to launch its early lung cancer detection liquid biopsy assay 4D Lifetest™ Lung Dx in Europe 15.07.2022 15:00, Tracy Woodley linkedIn facebook twitter insta... |
| 22.06.2021 | CE Certification for 4D Lifetec's cancer diagnostic platform | |
| 22.06.2021 | CE Certification for 4D Lifetec's cancer diagnostic platform | The patented 4D Lifetest Lung Dx and Breast Dx by 4D Lifetec are designed to evaluate DNA damage levels in peripheral blood mononuclear cells (PBMCs). The assays are based on a newly developed proprietary biomarker and have demonstrated out... |
| 05.03.2021 | 4D Lifetec AG with first customers and R&D partner | Founded in 2014 by an experienced team, 4D Lifetec AG developed its proprietary and fully patented 4D Lifetest for the early detection of cancer based on a new innovative biomarker and liquid biopsy. The test, which requires few millilitres... |
Show more